ARTICLE | Clinical News
Cel-Sci to begin Phase II trial
August 21, 2000 7:00 AM UTC
CVM said it received approval to begin an additional Phase II dose optimization trial with its Multikine cytokine mixture in the Czech Republic and Poland in 20 patients with previously untreated prim...